Mannatech (NASDAQ:MTEX) Now Covered by Analysts at StockNews.com

StockNews.com began coverage on shares of Mannatech (NASDAQ:MTEX) in a research note published on Monday. The brokerage issued a buy rating on the stock.

Mannatech Stock Down 3.7 %

Shares of NASDAQ:MTEX opened at $8.13 on Monday. Mannatech has a 52-week low of $6.75 and a 52-week high of $10.51. The stock has a market cap of $15.32 million, a P/E ratio of -10.03 and a beta of 1.17. The business’s 50 day moving average is $7.75 and its 200 day moving average is $7.54. The company has a quick ratio of 0.62, a current ratio of 1.25 and a debt-to-equity ratio of 0.44.

Mannatech (NASDAQ:MTEX) last announced its quarterly earnings data on Tuesday, November 12th. The company reported ($0.17) earnings per share (EPS) for the quarter. Mannatech had a negative return on equity of 15.62% and a negative net margin of 1.26%. The firm had revenue of $31.73 million during the quarter.

Insider Buying and Selling

In other Mannatech news, Director Larry A. Jobe sold 16,288 shares of the company’s stock in a transaction on Monday, September 9th. The stock was sold at an average price of $7.75, for a total transaction of $126,232.00. Following the completion of the sale, the director now owns 54,721 shares in the company, valued at $424,087.75. This represents a 22.94 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 41.50% of the stock is owned by insiders.

Mannatech Company Profile

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.